High-Temp Non-Partitioned HEPA Filters in Pharma & Biomed Process Ovens

Nov 07, 2025 Leave a message

Technical Application of High-Temperature Resistant, Non-Partitioned HEPA Filters in Process Ovens for the Pharmaceutical and Biomedical Industry

The application of high-temperature resistant, non-partitioned HEPA filters in process ovens within the pharmaceutical and biomedical industry is a crucial step in ensuring drug quality and compliance with regulatory requirements. Unlike ordinary industrial ovens, these ovens have extremely stringent requirements for cleanliness and sterility. Below is a detailed technical application description:

 

I. Application Segments and Core Functions

1. Application Equipment: Process ovens, which are specialized equipment used in the pharmaceutical production process for heating, drying, sterilizing, or depyrogenating materials, tools, and equipment components.

2. Specific Uses:
- 2.1 Material Drying: Such as the drying of powders or crystals of antibiotics and active pharmaceutical ingredients.
- 2.2 Tool Sterilization: Dry heat sterilization of stainless steel accessories, glassware, silicone tubes, etc. (usually requiring temperatures above 180℃ for 2 hours).
- 2.3 Depyrogenation: High-temperature treatment of inner packaging materials (such as rubber stoppers, vials) or equipment components that come into direct contact with injectables to destroy bacterial endotoxins (usually requiring temperatures above 250℃ for over 30 minutes).

3. Application Location: Installed at the end of the process oven's air supply system, i.e., the last purification checkpoint that the heated air must pass through before entering the oven chamber after being heated by the heater.

4. Core Functions:
- 1 Providing Clean Hot Air: Ensuring that the hot air entering the oven's working area is clean and meets the required cleanliness level (usually A or B grade background), preventing secondary contamination of the product by particles and microorganisms in the air during drying or sterilization.
- 4.2 Ensuring Process Effectiveness**: For sterilization and depyrogenation processes, if the hot air itself is contaminated with bacteria or endotoxins, the entire process will fail. The HEPA filter is the foundation for ensuring process effectiveness.
- 4.3 Protecting Product Purity: Preventing particle contamination from affecting the quality of high-purity active pharmaceutical ingredients or intermediates.

 

II. Why Must "High-Temperature Resistant" and "High-Efficiency" Filters Be Used in This Segment?

1. High-Temperature Resistance (usually required between 250℃ - 350℃):
- 1.1 Process Requirements: Depyrogenation process temperatures reach above 250℃, and sterilization processes often occur at 180℃ - 220℃. Ordinary filters cannot work stably at these temperatures in the long term.
- 1.2 Material Stability**: High-temperature resistant filters use stainless steel frames, high-temperature resistant sealants, and glass fiber filter paper, ensuring no decomposition, release of pollutants, or deformation under long-term high-temperature conditions, guaranteeing continuous and effective filtration performance.

2. High-Efficiency Filtration (must reach H13/H14 levels):
- 2.1 Target of Capture**: Capturing all bacteria and particles. Bacteria are usually larger than 0.5μm, but the carrier particles they adhere to may be smaller. H13 level (efficiency for 0.3μm particles ≥99.97%) or H14 level (≥99.995%) is the basic requirement to ensure the interception of microorganisms.
- 2.2 Regulatory Compliance: Pharmaceutical GMP (Good Manufacturing Practice) requires that core areas of sterile drug production (including the interior of some process ovens) achieve A-grade cleanliness, which must be realized through high-efficiency filters.
- 2.3 Advantages of Non-Partitioned Design:
- 2.3.1 Low Risk of Shedding**: Without metal partitions, the risk of metal shavings shedding and contaminating the product is fundamentally avoided, which is crucial for injectable production.
- 2.3.2 High Dust Holding Capacity: The optimized structure has a higher dust holding capacity, suitable for batch and continuous production conditions, extending the replacement cycle.
- 2.3.3 Easy to Validate: The simple structure facilitates leak testing.

 

III. Specific Technical Requirements and Industry Characteristics

1. Strict GMP Compliance Requirements:
- Material Certification: All components in contact with clean air (frames, filter media, sealants) must provide material certifications that comply with pharmaceutical regulations, such as **FDA or USP Class VI, to ensure they are non-toxic, non-shedding, and corrosion-resistant.
- Surface Finish: The filter frame should be easy to clean, with a high surface finish to prevent dust accumulation and bacterial growth.

2. Complete Validation (DQ, IQ, OQ, PQ):
- 2.1 Installation Qualification (IQ): Confirming the correct model, specifications, and installation method of the filter.
- 2.2 Operational Qualification (OQ): The core part is to conduct on-site PAO/DOP smoke scan leak tests to ensure there are no leaks (zero leakage standard) in the filter and its seal with the installation frame. It is also necessary to test the air velocity and temperature uniformity at various points in the oven.
- 2.3 Performance Qualification (PQ): By loading actual or simulated products, it is verified that the oven can continuously and stably produce products that meet the predetermined standards (such as sterility, depyrogenation) under the set process parameters.

3. Traceability and Documentation: Each filter should have a unique identification number and a complete traceable document package, including factory inspection reports, material certifications, certificates of conformity, etc., for regulatory audits.

 

IV. Summary of Application Value and Importance

1. Foundation of Drug Safety: It is directly related to the sterility and depyrogenation of drugs, especially injectables, and is an important safeguard for patient medication safety.
2. Prerequisite for Regulatory Compliance: It is a mandatory requirement to meet the regulatory requirements of global mainstream pharmaceutical regulatory authorities such as China GMP, US FDA, and EU GMP, with no room for compromise.
3. Ensuring Product Quality and Consistency: Preventing contamination and ensuring that each batch of products meets the predetermined quality standards.
4. Avoiding Huge Risks: If a batch of products is contaminated due to air pollution, it will cause significant economic losses and damage to the company's reputation.

 

Conclusion: In the process ovens of the pharmaceutical and biomedical industry, high-temperature resistant, non-partitioned HEPA filters have long surpassed the category of simple "ventilation components"; they are a key "process quality assurance component." The reliability of their performance is directly integrated into the quality attributes of drugs. The selection, installation, validation, and maintenance of such filters are among the most rigorous and regulated activities in a pharmaceutical company's quality system, reflecting the concept of "quality by design."